Harmony Biosciences Holdings, Inc. appointed Sandip Kapadia, the Company?s Chief Financial Officer, to the title of Chief Financial Officer and Chief Administrative Officer, effective upon Mr. Kapadia?s acceptance on September 30, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 USD | -2.27% | +0.92% | -8.42% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.42% | 1.71B | |
+39.75% | 723B | |
+34.28% | 595B | |
-3.63% | 369B | |
+20.29% | 332B | |
+2.88% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.10% | 168B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Holdings, Inc. Appoints Sandip Kapadia as Chief Administrative Officer